Skip to main content
Veterinary Medicines

Advantix Spot-on solution for dogs over 10 kg up to 25 kg

Authorised
  • Permethrin (40:60)
  • Imidacloprid

Product identification

Medicine name:
Advantix Spot-on solution for dogs over 10 kg up to 25 kg
Advantix spot on pre psy od 10 do 25 kg
Active substance:
  • Permethrin (40:60)
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Spot-on use

Product details

Active substance and strength:
  • Permethrin (40:60)
    1250.00
    milligram(s)
    /
    1.00
    Pipette
  • Imidacloprid
    250.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Spot-on use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AC54
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:
  • Pack with 24 short-neck tube pipettes
  • Pack with 6 short-neck tube pipettes
  • Pack with 4 short-neck tube pipettes
  • Pack with 3 short-neck tube pipettes
  • Pack with 2 short-neck tube pipettes
  • Pack with 1 short-neck tube pipette

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma + Veterinaer Produkte GmbH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/017/MR/04-S
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0115/001
Concerned member states:
  • Austria
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Netherlands
  • Norway
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 5/11/2024
Download
Italian (PDF)
Published on: 8/02/2022
Updated on: 16/01/2023
Slovak (PDF)
Published on: 8/02/2022
Updated on: 16/01/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."